Learn More
Medchemexpress LLC SAH-SOS1A TFA | 2896737-31-6 | 96.6% | 2301.55 | 5 MG

Supplier: Medchemexpress LLC HYP2265A5MG
SAH-SOS1A TFA is a peptide-based SOS1/KRAS protein interaction inhibitor that binds to wild-type and mutant KRAS (G12D, G12V, G12C, G12S, and Q61H) with nanomolar affinity (EC50=106-175 nM). This compound directly and independently blocks nucleotide association, impairs KRAS-driven cancer cell viability, and exerts its effects by on-mechanism blockade of the ERK-MAPK phosphosignaling cascade downstream of KRAS. It is intended for research use only.
- Binds to wild-type and mutant KRAS (G12D, G12V, G12C, G12S, Q61H) with nanomolar affinity
- Directly blocks nucleotide association
- Impairs KRAS-driven cancer cell viability
- Blocks ERK-MAPK phosphosignaling cascade downstream of KRAS
- Exhibits IC50 values in 5-15 μM range for cancer cells with KRAS mutations
- Inhibits MEK1/2, ERK1/2, and AKT phosphorylation in vitro
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.